dr. schwartzberg on increasing competition with biosimilars in oncology
Published 4 years ago • 63 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
1:48
dr. markman on the concept of biosimilars in oncology
-
0:49
lee schwartzberg, md, facp: biosimilar filgrastim and neutropenia
-
1:48
lee schwartzberg, md, facp: challenges with incorporating biosimilars in the clinic
-
0:48
lee schwartzberg, md, facp: biosimilar education for oncologists
-
3:33
biosimilars: manufacturing and inherent variation
-
44:08
15-years of biosimilars in europe: what lessons can we share? - panel 1
-
4:20
the biosimilar development process
-
0:42
dr. cristofanilli on the need for biosimilars in oncology
-
7:22
an overview of biosimilarity
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
0:55
dr. slamon discusses the future of biosimilars in oncology
-
0:45
dr. preeshagul on education for biosimilars in oncology
-
7:20
biosimilars in oncology: addressing awareness
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
51:06
biosimilars and oncology clinical pathways: perfect together
-
0:49
dr. robson discusses differences between biosimilars and biologics in oncology
-
2:40
biosimilars: a new approach to cancer treatment in brazil
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
5:16
biosimilars: what oncologists need to know
-
1:42
dr. verma discusses challenges with biosimilars in oncology